Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

Published on by Genetics and Genomics

Prof Bassam Al-Naami | Cognitive Neuropsychiatry | Excellence Award(Any Scientific Field)

The Hashemite University | Jordan 

Author Profile

Scopus

Orcid ID

Google Scholar

📘 BASSAM AL-NAAMI, PH.D. – BIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

PH.D. IN MEDICAL ELECTRONICS AND ERGONOMICS From 1997 to 2000, Dr. Bassam Al-Naami pursued his Ph.D. at the Saint Petersburg State Electrotechnical University (LETI), Russia. His research was centered on Interaction Efficiency of Operational Virtual Reality Systems with an Operator, a project merging biomedical engineering and television and video engineering. His doctoral work emphasized ergonomics, human factors, and the integration of technology to improve operator interaction in virtual systems. VISITING RESEARCH FELLOWSHIP IN SIGNAL & IMAGE PROCESSING From 2001 to 2003, Dr. Al-Naami completed a Visiting Research Fellowship at the University of Sussex, Brighton, UK. He collaborated with notable researchers, including Dr. John Torry, Dr. Mark English, and Prof. Richard Vincent, focusing on wavelet domain signal processing. DIPLOMA IN BIOMEDICAL ENGINEERING/MEDICAL ELECTRONICS His foundational academic journey began at Stavropol State Technical University, Russia, where he earned a Five-Year Honors Diploma in Biomedical Engineering and Medical Electronics (1992–1997). This laid the groundwork for his future in medical instrumentation and signal processing.

💼 PROFESSIONAL ENDEAVORS

PROFESSOR & DEPARTMENT CHAIR Currently, Dr. Al-Naami holds the position of Professor and Department Chair of Biomedical Engineering at Hashemite University (HU) in Jordan. His career spans over two decades, during which he also served as Vice Dean of Student Affairs (2014–2015) and Dean Assistant of Engineering Faculty (2010–2012). ABET ACCREDITATION LEADER Dr. Al-Naami has been deeply involved in academic accreditation efforts, serving as the ABET Coordinator at Hashemite University. His leadership in developing academic programs, ensuring quality standards, and facilitating ABET accreditation for the Biomedical Engineering department at HU has significantly enhanced the institution’s academic reputation. Additionally, he was pivotal in founding the Master’s Program in Biomedical Engineering at HU during the academic year 2022-2023. ADMINISTRATIVE ROLES & TEACHING Beyond accreditation, Dr. Al-Naami has served on multiple academic committees, contributed to curriculum development, and mentored over 70 final-year engineering projects. He has extensive teaching experience in medical imaging, biomedical instrumentation, and advanced signal processing.

🧬 CONTRIBUTIONS AND RESEARCH FOCUS ON COGNITIVE NEUROPSYCHIATRY

SIGNAL AND IMAGE PROCESSING Dr. Al-Naami's research has a notable focus on signal and image processing in clinical settings, exploring:

  • ECG, cardiac ischemia, and arrhythmias
  • Automated detection of sleep apnea
  • Neurological disorders like Alzheimer’s and multiple sclerosis
  • Cancer detection via CT and MRI images

MEDICAL INSTRUMENTATION & NON-INVASIVE TECHNOLOGIES He has advanced the development of non-invasive diagnostic tools including devices for:

  • Hemoglobin measurement
  • Lung sound analysis
  • Wound healing automation systems

His pioneering work in field-programmable gate arrays (FPGA) for medical applications has contributed to real-time health monitoring systems. ERGONOMICS & VIRTUAL REALITY Dr. Al-Naami has been at the forefront of ergonomics and virtual reality (VR) research, using haptic devices and VR systems to improve training for medical professionals. His research into the physiological impacts of VR, including visual and muscle fatigue, has influenced both the medical and industrial sectors.

🌍 IMPACT AND INFLUENCE

Dr. Al-Naami’s contributions have significantly impacted medical technology and biomedical engineering across the Middle East and internationally. His leadership in academic accreditation and program development has shaped the next generation of biomedical engineers in Jordan. Through his research, he has improved diagnostic techniques in critical areas such as cancer detection, heart disease, and neurology. His collaboration with global institutions like the University of Sussex and the Jordanian Engineering Association further amplifies his influence.

📊 ACADEMIC CITES

Dr. Al-Naami's work has been widely cited in academic and clinical research papers. His findings on non-invasive medical diagnostics, image processing, and signal analysis are frequently referenced in journals related to biomedical engineering and medical instrumentation.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

AWARDS & RECOGNITION
Dr. Al-Naami has been recognized for his outstanding contributions with multiple accolades, including:

  • IEEE Senior Membership (2023)
  • Excellence in Scientific Research Award from Hashemite University (2013/2014)
  • Best Project Award at Saint Petersburg LETI (1999)

His legacy in shaping the biomedical engineering field through teaching, research, and administrative leadership is remarkable. Moving forward, Dr. Al-Naami aims to continue his research in AI-driven medical diagnostics and expand his work in non-invasive medical devices. FUTURE CONTRIBUTIONS As technology evolves, Dr. Al-Naami’s ongoing projects in deep learning for medical imaging and thermographic analysis for hemoglobin levels will likely redefine diagnostic practices. His focus on IoT in healthcare is set to create innovative solutions for remote patient monitoring and improved healthcare delivery.

📚 TEACHING EXPERIENCE

Dr. Al-Naami has taught a diverse array of undergraduate and postgraduate courses, including:

  • Biomedical Instrumentation I & II
  • Medical Imaging Modalities
  • Digital Image Processing
  • Medical Device Design & Development

His commitment to education is evident in his student mentorship, advising over 70 final-year projects across biomedical, electrical, and mechanical engineering disciplines.

🔬 RESEARCH PROJECTS

Dr. Al-Naami has spearheaded numerous funded research projects. Key projects include:

  • Non-invasive hemoglobin measurement using advanced image processing and deep learning
  • Kidney stone detection using artificial intelligence
  • Automated hand dexterity monitoring systems for post-stroke patients

His collaborations with institutions such as Al-Bashir Government Hospital and Jordan University Hospital have enhanced clinical research applications in Jordan.

🌟 PROFESSIONAL AFFILIATIONS

Dr. Al-Naami is a Senior Member of IEEE and a member of the Jordanian Engineering Association. He has actively contributed to professional societies, such as the IEEE Engineering in Medicine and Biology Society, playing a vital role in advancing the field of biomedical engineering globally.

📑NOTABLE PUBLICATIONS 

"Electromyography Monitoring Systems in Rehabilitation: A Review of Clinical Applications, Wearable Devices and Signal Acquisition Methodologies" 

  • Authors: Al-Ayyad, M. , Owida, H.A. , De Fazio, R. , Al-Naami, B. , Visconti, P.
  • Journal: Electronics
  • Year: 2023

"IoT Solutions and AI-Based Frameworks for Masked-Face and Face Recognition to Fight the COVID-19 Pandemic" 

  • Authors: Al-Nabulsi, J. , Turab, N. , Owida, H.A. , ... De Fazio, R. , Visconti, P.
  • Journal: Sensors
  • Year: 2023

"Improved recovery of cardiac auscultation sounds using modified cosine transform and LSTM-based masking"

  • Authors: Al-Zaben, A. , Al-Fahoum, A. , Ababneh, M. , Al-Naami, B. , Al-Omari, G.
  • Journal: Medical and Biological Engineering and Computing
  • Year: 2024

"Advanced Low-Pass Filters for Signal Processing: A Comparative Study on Gaussian, Mittag-Leffler, and Savitzky-Golay Filters"

  • Authors: Rawash, Y.Z. , Al‐Naami, B. , Alfraihat, A. , Owida, H.A.
  • Journal: Mathematical Modelling of Engineering Problems
  • Year: 2024

"Automated Lung Cancer Diagnosis Applying Butterworth Filtering, Bi-Level Feature Extraction, and Sparce Convolutional Neural Network to Luna 16 CT Images"

  • Authors: Gharaibeh, N.Y. , De Fazio, R. , Al-Naami, B. , Al-Hinnawi, A.-R. , Visconti, P.
  • Journal: Journal of Imaging
  • Year: 2024

Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

Published on by Genetics and Genomics

Dr. Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

University of Buea | Cameroon

Author Profile

Scopus

Biography of Dr. Ofon Elvis Amih 🌍🧬

EARLY ACADEMIC PURSUITS 🎓

Dr. Ofon Elvis Amih’s academic journey is rooted in his commitment to biochemistry, starting with his undergraduate studies at the University of Dschang, Cameroon. From 2006 to 2010, he pursued a Bachelor of Science in Biochemistry with a specialty in Clinical Biochemistry. His passion for this field led him to continue his studies at the same institution, where he earned a Master of Science in Biochemistry between 2010 and 2013, further specializing in Clinical Biochemistry. In 2014, Dr. Amih embarked on his doctoral studies, culminating in a PhD in Biochemistry with a specialty in Clinical Biochemistry from the University of Dschang in 2019. His doctoral research solidified his expertise in biochemistry and set the stage for his future contributions to the field.

PROFESSIONAL ENDEAVORS AND TEACHING 📚

Dr. Amih’s career in academia began at the University of Dschang, where he served as a Graduate Teaching Monitor from 2014 to 2021. In this role, he assisted in tutorials, practical lessons, and exam invigilation. His teaching career advanced further when he joined the University of Buea as an Assistant Lecturer at the Faculty of Health Sciences in October 2021. His work at the University of Buea involves mentoring students and imparting valuable knowledge in the field of biochemistry. In addition to teaching, Dr. Amih engaged in postdoctoral research with the TrypanoGEN+ Consortium from 2019 to 2022, where he worked on groundbreaking research related to genome-wide association studies (GWAS). Furthermore, he became a Bioinformatics Fellow with H3Abionet/H3Africa, contributing to the intersection of bioinformatics and biochemistry through collaborative projects across Africa.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🔬

Dr. Amih's research is deeply focused on the genetic markers associated with Human African Trypanosomiasis (HAT). His manuscript, currently in press, titled "A Genome-wide association study reveals novel genetic markers associated with Human African Trypanosomiasis," marks a significant contribution to understanding this tropical disease. His research work bridges biochemistry and bioinformatics, with an emphasis on using advanced genomic tools to address pressing health issues in Africa.

IMPACT AND INFLUENCE 🌟

Dr. Amih has had a considerable influence in his field, particularly through his involvement in internationally recognized initiatives like the TrypanoGEN+ Consortium and H3Abionet/H3Africa. His contributions extend beyond research, as he is also shaping future generations of scientists and biochemists through his academic roles. His work has impacted the global scientific community, with his insights contributing to scientific journals and conferences worldwide. He has actively participated in numerous workshops and conferences, from local events in Cameroon to international collaborations, such as the H3ABioNet Online ‘Introduction to Bioinformatics’ training course in South Africa.

ACADEMIC CITATIONS AND PUBLICATIONS🏅

Dr. Amih’s academic impact is further validated by his involvement in journal review activities for reputable publications such as Plos Computational Biology and the Journal of Bioscience and Medicine. His own manuscripts, particularly the upcoming publication on genetic markers for Human African Trypanosomiasis, are anticipated to contribute valuable citations in the field of clinical biochemistry and tropical disease research.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

As Dr. Amih continues his academic and research endeavors, his legacy is likely to be defined by his contributions to both biochemistry and bioinformatics. His ongoing role at the University of Buea, coupled with his research collaborations across Africa, ensures that his work will leave a lasting impact on the scientific community, particularly in the areas of neglected tropical diseases and genetic research. Looking ahead, Dr. Amih is poised to expand his contributions through more collaborative research projects, potentially leading future generations of scientists and continuing to address critical health challenges in Africa. His deep expertise in both biochemistry and bioinformatics uniquely positions him as a leader in these intertwined disciplines.

NOTABLE PUBLICATIONS 📑

"High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation" 

  • Authors: Mulindwa, J., Noyes, H., Ilboudo, H., Ahouty, B., & Kabore, J.
  • Journal: Human Genetics
  • Year: 2020

"Copy number variation in human genomes from three major ethno-linguistic groups in Africa" 

  • Authors: Nyangiri, O.A. , Noyes, H. , Mulindwa, J. ,Hertz-Fowler, C. , Matovu, E.
  • Journal: Genomics
  • Year: 2020

"Molecular identification of different trypanosome species in tsetse flies caught in the wildlife reserve of Santchou in the western region of Cameroon"

  • Authors: Kamdem, C.N. , Tiofack, A.A.Z. , Mewamba, E.M. , Gomseu, E.B.D. , Simo, G.
  • Journal: Parasitology Research
  • Year: 2020

"Association between polymorphisms of IL4, IL13, IL10, STAT6 and IFNG genes, cytokines and immunoglobulin E levels with high burden of Schistosoma mansoni in children from schistosomiasis endemic areas of Cameroon"

  • Authors: Mewamba, E.M. , Noyes, H. , Tiofack, A.A.Z. , MacLeod, A. , Simo, G.
  • Journal: Genetics and Evolution
  • Year: 2023

"Evaluation of ITS1 rDNA primers for the detection and identification of African trypanosomes in mammalian hosts and tsetse flies."

  • Authors: Ofon, E.A. , Metiadjoue, M.C.C. , Kante, S.T. ,Fogue, S.P. , Simo, G.
  • Journal: Acta Tropica
  • Year: 2024

Jun Tian | Movement Disorder | Best Researcher Award

Published on by Genetics and Genomics

Dr. Jun Tian | Movement Disorder | Best Researcher Award

2nd Affiliated Hospital, Zhejiang University, School of Medicine | China

🧠 JUN TIAN: A PIONEER IN NEUROLOGICAL RESEARCH

EARLY ACADEMIC PURSUITS 📚

Jun Tian began his academic journey at Zhejiang University, one of the leading institutions in China, where he obtained his Bachelor's degree in Clinical Medicine (1999-2004). His passion for neurology led him to pursue further specialization, earning a Master's degree in Neurology (2004-2006) from the same institution. During these formative years, he developed a strong foundation in the study of neurological disorders, setting the stage for his future contributions to the field. His academic pursuits culminated in a Ph.D. in Neurology (2009-2013), where he focused on the molecular and cellular mechanisms behind neurodegenerative diseases, particularly Parkinson’s disease.

PROFESSIONAL ENDEAVORS 👩‍⚕️

Jun Tian's professional career took flight in 2006, when he began working as a Resident in the Department of Geriatrics at the Second Affiliated Hospital, School of Medicine, Zhejiang University. His work during this time exposed him to a wide range of neurological conditions affecting older adults, deepening his clinical expertise. In 2009, he transitioned to a Fellowship position in the Department of Neurology at the same institution. In this role, he gained further clinical experience while also pursuing cutting-edge research in neurological disorders, with a particular focus on movement disorders such as Parkinson’s disease and Huntington’s disease.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOVEMENT DISORDER 🔬

Jun Tian’s research has primarily centered on the mechanisms behind neurodegenerative diseases, particularly Parkinson's disease and Huntington’s disease. His work has explored key issues such as mitochondrial dysfunction in neurons and the role of specific neural pathways in disease progression. He has presented his research at multiple prestigious international conferences, including:

  • 2013 at the 17th International Congress of Parkinson’s Disease and Movement Disorders in Australia, where he presented a guided poster tour on mutant Huntingtin protein’s impact on mitochondrial axonal transport in cultured hippocampal neurons.
  • 2014 at the 4th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress in Thailand, where he discussed the effects of optical stimulation of glutamatergic afferent fibers in neural pathways.

IMPACT AND INFLUENCE 🌍

Jun Tian’s research has made significant contributions to the understanding of how neurodegenerative diseases impair neuronal function. His work on mitochondrial axonal transport has provided new insights into the mechanisms by which diseases like Huntington’s affect neuron health, potentially opening new avenues for therapeutic interventions. In addition to his clinical and research roles, he has been recognized for his academic excellence with the prestigious Gekequan Scholarship from Zhejiang University in 2011. This award reflects the high regard his peers and mentors have for his dedication and talent.

ACADEMIC CITATIONS AND SCHOLARLY IMPACT 🏅

Jun Tian’s research, presented at leading international conferences, has been well-received in the academic community. Although specific details about his publications are limited, his work on Parkinson’s disease and mitochondrial dysfunction has the potential to influence future research in these areas, contributing to the growing body of knowledge on how neurodegenerative diseases can be treated or managed.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Jun Tian is well on his way to establishing a lasting legacy in the field of neurology, particularly in the study of neurodegenerative diseases. His work has already made significant strides in understanding how neurological disorders affect cellular mechanisms, and future research could lead to breakthroughs in treatment strategies for patients suffering from these debilitating conditions. Looking forward, Jun Tian’s contributions to neurology will likely continue to grow, both through his clinical work and his research efforts. His participation in international forums and collaborations with leading researchers will further enhance his impact in the field, ensuring that his legacy endures for future generations of neurologists and researchers.

NOTABLE PUBLICATIONS 📑

"Alzheimer Disease and Epilepsy: A Mendelian Randomization Study" 

  • Authors: Fang, Y., Si, X., Wang, J., Zhang, B., Pu, J
  • Journal: Neurology
  • Year: 2023

"The clinical characteristics of neuronal intranuclear inclusion disease and its relation with inflammation" 

  • Authors: Yan, Y., Cao, L., Gu, L., Zhang, B., Zhao, G.
  • Journal: Neurological Sciences
  • Year: 2023

"Elevated serum anti-Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease"

  • Authors: Chen, Y., Zhang, L.-Y., Fang, Y., Zhang, B.-R., Pu, J.-L.
  • Journal: European Journal of Neurology
  • Year: 2023

"Cytokine and chemokine map of peripheral specific immune cell subsets in Parkinson’s disease"

  • Authors: Jiang, S.-S., Wang, Y.-L., Xu, Q.-H., Tian, J., Pu, J.-L.
  • Journal: npj Parkinson's Disease
  • Year: 2023

"The longitudinal volumetric and shape changes of subcortical nuclei in Parkinson’s disease"

  • Authors: Yang, W., Bai, X., Guan, X., Pu, J., Tian, J.
  • Journal: Scientific Reports
  • Year: 2024

Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Published on by Genetics and Genomics

Dr. Kuangyn Yen | Gene Regulation and Epigenetics | Best Researcher Award

Chinese Academy of Medical Sciences and Peking Union Medical College | China 

Author Profile

Scopus 

Orcid ID

📘 KUANGYU YEN, PhD: PIONEER IN TRANSCRIPTION REGULATION AND CHROMATIN DYNAMICS

🎓 EARLY ACADEMIC PURSUITS

Kuangyu Yen's academic journey began at National Taiwan University, where he earned a Bachelor of Science in Horticulture (Molecular Biology Unit) in 1998. His passion for molecular biology led him to pursue advanced degrees at the University of Manchester, UK, where he completed both an MRes (2001) and a Ph.D. in Molecular Biology (2005). His doctoral research laid the foundation for his expertise in transcription regulation, setting the stage for his future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Dr. Yen's professional career is marked by a blend of international experiences and prestigious appointments:

  • Chinese Academy of Medical Sciences & Peking Union Medical College (2022-present): Researcher.
  • Southern Medical University (2014-2022): Professor, where he contributed significantly to the academic and research community in Guangzhou, China.
  • Pennsylvania State University (2008-2014): Post-doctoral fellow and later Research Assistant Professor, expanding his expertise in transcription regulation and chromatin dynamics.
  • University of Washington (2005-2007): Post-doctoral fellow, further deepening his understanding of molecular biology at the intersection of chromatin and transcription.
  • National Taiwan University (1998-2000): Research Assistant, where his scientific curiosity began to flourish.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATION AND EPIGENETICS

Dr. Yen's research focus is on transcription regulation and its influence on cell fate determination, particularly through chromatin dynamics. His innovative use of bioinformatic tools, CRISPR/Cas9-engineered depletion, and biochemical reconstitution has made him a leader in understanding how chromatin regulates transcription in a spatiotemporal manner. His research has significant implications for disease diagnosis and treatment, especially in preventing precancerous cells from progressing into cancer cells. One of his notable contributions is the development of a two-tipping point model, which helps explain how cell fate transitions. This model has potential applications in both basic research and clinical practice, offering insights into the molecular mechanisms of various diseases.

🌍 IMPACT AND INFLUENCE

Dr. Yen’s work has been internationally recognized, and he has secured multiple high-profile grants and awards, such as the Thousand Youth Talents Award and the Outstanding Youth Award. His research has attracted funding from the National Natural Science Foundation of China, the National Key Research and Development Program of China, and international collaborations such as the France-China Joint Research Projects Program. His influence extends to key speaking engagements and workshops in the field of epigenetics and hematopoiesis at global institutions, including John Hopkins University.

📊 ACADEMIC CITATIONS

With several publications to his name, Dr. Yen’s work is well-cited in the scientific community, reinforcing his status as an influential researcher in molecular biology. His contributions to understanding transcription regulation and chromatin dynamics continue to resonate, particularly in the areas of epigenetics and hematopoiesis.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kuangyu Yen’s legacy will likely center on his pioneering research into how chromatin structure affects transcriptional regulation and cell fate transitions. His use of cutting-edge tools like CRISPR/Cas9 and bioinformatics has laid the groundwork for future advancements in cancer prevention and molecular diagnostics. Moving forward, Dr. Yen’s ongoing research at the Chinese Academy of Medical Sciences is poised to further influence how scientists understand and manipulate transcription regulation. His editorial role at Communication Biology (2024-2026) and other professional activities suggest that his contributions to the field are far from over.

🚀 AWARDS AND PROFESSIONAL RECOGNITION

  • National Natural Science Foundation of China: Multiple grants for outstanding research, totaling over 500,000 USD.
  • Thousand Youth Talents Award: A prestigious recognition with funding of 0.67 million USD.
  • Numerous invited talks at top-tier institutions and international conferences.

Kuangyu Yen’s continuous dedication to his research and the academic community positions him as a transformative figure in molecular biology, with future contributions set to further shape the field.

📅 FUTURE HIGHLIGHTS

Dr. Yen’s ongoing projects and his active engagement with the scientific community, including participation in international editorial boards and professional panels, indicate that his work will continue to shape the future of molecular biology research for years to come.

📑NOTABLE PUBLICATIONS 

"RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation" 

  • Authors: Liu, S., Yang, J., Sun, G., Yen, K., & Lu, T. (2021).
  • Journal: Molecular Biosciences
  • Year: 2021

"Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae" 

  • Authors: Lai, S., Kumari, A., Liu, J., Yen, K., & Xu, J.
  • Journal: Genetics and Genomics
  • Year: 2021

"Comprehensive understanding of Tn5 insertion preference improves transcription regulatory element identification"

  • Authors: Zhang, H., Lu, T., Liu, S., Chen, F., & Yen, K.
  • Journal: NAR Genomics and Bioinformatics
  • Year: 2021

"Functional Verification of Novel ELMO1 Variants by Live Imaging in Zebrafish"

  • Authors: Xue, R., Wang, Y., Wang, T., Liu, Q., & Xu, J.
  • Journal: Frontiers in Cell and Developmental Biology
  • Year: 2021

"SPI1-KLF1/LYL1 axis regulates lineage commitment during endothelial-to-hematopoietic transition from human pluripotent stem cells"

  • Authors: Qu, K., Mo, S., Huang, J., Shen, J., & Yen, K.
  • Journal: iScience
  • Year: 2024

Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

Published on by Genetics and Genomics

Dr. Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

University Health Authority of Central Friuli | Italy

Author Profile

Scopus
Orcid ID

Biography of Flavio Faletra: A Leader in Medical Genetics 🧬

EARLY ACADEMIC PURSUITS 🎓

Flavio Faletra began his distinguished academic journey at the University of Trieste, where he earned a Degree in Medicine and Surgery in 2005. He further specialized in Medical Genetics at the same institution, completing his specialization in 2009. Demonstrating a strong commitment to his field, Faletra pursued advanced education with a Second-level Master’s degree in Clinical Genetics from the University of Siena in 2011. His foundational academic achievements laid the groundwork for a career focused on the intersection of genetics and clinical medicine.

PROFESSIONAL ENDEAVORS 🏥

Flavio Faletra has held multiple pivotal roles in medical genetics. Since August 2023, he has been an Expert in Genetics at the Regional Health Coordination Agency (ARCS) in Friuli Venezia Giulia, Italy. Alongside his expert role, he has been a University Lecturer on contract at the University of Trieste from 2018 to 2023, contributing to the academic growth of students in the field of genetics. His professional journey includes numerous positions as a Medical Director I Level in Medical Genetics, starting with the IRCCS Burlo Garofolo (2013–2017) and progressing through roles in University Health Authority Friuli Centrale and IRCCS Burlo Garofolo until his current position, reflecting his leadership in the medical genetics field.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR GENETICS AND GENOMICS  🔬

Faletra’s research focus spans various critical areas of medical genetics, from pediatric endocrinology to rare genetic diseases. He has contributed extensively to genetic counseling and clinical genetics, with a strong emphasis on pediatric genetic disorders. His work as a Thesis Co-Surveyor and PhD Supervisor at the University of Trieste demonstrates his dedication to nurturing the next generation of geneticists. Through courses such as the Genetic Consulting in Medical Genetics Specialization School, he has shaped the landscape of medical genetics education. His involvement in pediatric endocrinology through ADE courses has brought syndromic genetic disorders to the forefront, significantly impacting the medical community’s approach to these conditions.

IMPACT AND INFLUENCE 🌍

Faletra’s influence extends beyond academia into clinical practice, where his expertise has helped shape genetic diagnostic strategies across Italy. His participation in national conferences, such as the National Congress of Human Genetics and seminars on genetic syndromes and diagnostics, marks him as a key figure in Italian medical genetics. Faletra's teaching and research efforts have particularly impacted the areas of growth retardation, fetal malformations, and syndromic genetic disorders, positioning him as a central figure in advancing genetic medicine in pediatrics.

ACADEMIC CITES 📚

Flavio Faletra's work has been cited in numerous academic publications, with topics ranging from genetic diagnostic methods to therapeutic approaches for rare genetic disorders. His research in exome sequencing and next-generation sequencing techniques has had a broad impact, being referenced widely in the fields of human genetics and pediatric medicine.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Faletra’s legacy lies in his dedication to medical genetics, particularly in the areas of pediatric syndromic diseases and clinical genetics. His contribution to education, research, and clinical practice has left an indelible mark on the field. Looking ahead, his ongoing role as an expert and lecturer promises continued contributions to genomic medicine and the advancement of personalized treatment for genetic disorders. Through his continuous involvement in research, teaching, and clinical practice, Faletra remains at the forefront of innovation in medical genetics, with the potential to further revolutionize the diagnosis and treatment of complex genetic diseases.

NOTABLE PUBLICATIONS 📑

"SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability" 

  • Authors: Bogaert, E., Garde, A., Gautier, T., Dermaut, B., Vitobello, A.
  • Journal: American Journal of Human Genetics
  • Year: 2023

"Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders" 

  • Authors:Di Stazio, M., Zanus, C., Faletra, F., d’Adamo, A.P., Musante, L.
  • Journal: Genes
  • Year: 2023

"A new neurodevelopmental disorder linked to heterozygous variants in UNC79"

  • Authors: A., Liu, Z., Luo, S., Liao, W., & Ren, D.
  • Journal: Genetics in Medicine
  • Year: 2023

"The clinical impact of the first-trimester nuchal translucency between the 95th–99th percentiles"

  • Authors: Fantasia, I., Catagini, S., Zamagni, G., Feresin, A., & Stampalija, T.
  • Journal: Prenatal Diagnosis
  • Year: 2023

"A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases"

  • Authors: Zucco, J., Baldan, F., Allegri, L., Damante, G., Mio, C.
  • Journal: Journal of Human Genetics
  • Year: 2024

Gang liu | Cancer | Best Researcher Award

Published on by Genetics and Genomics

Prof Gang liu | Cancer | Best Researcher Award

Gansu Provincial Center for Disease Control and Prevention | China

Author Profile

Scopus

Gang Liu: Pioneer in Radiobiology and Preventive Medicine ⚛️

EARLY ACADEMIC PURSUITS 🎓

Gang Liu began his academic journey at Lanzhou University, where he pursued a PhD in preventive medicine. His graduation in 1997 marked the beginning of a career dedicated to understanding the impacts of radiation on health. His academic training in preventive medicine provided the foundation for his future contributions to radiobiology and public health, particularly in the context of disease control and prevention.

PROFESSIONAL ENDEAVORS 🏢

After obtaining his PhD, Gang Liu embarked on a distinguished career at the Gansu Provincial Center for Disease Control and Prevention. His professional focus has been on the intersection of radiobiology, immunology, and tumor screening. In 2019, his registration as a health physicist signaled a significant milestone. He became the technical lead for a groundbreaking study on low-dose dose-effect relationships, a critical area in radiation therapy and safety. His expertise in radiation protection and therapy has earned him a prominent position within the medical research community.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER🧬

Gang Liu's research primarily revolves around radiobiology and radiation protection in therapy. His technological advancements in biological dose estimation are considered cutting-edge within China and recognized internationally. One of his significant contributions was revising the 2011 IAEA Manual based on findings from his studies on radiological sensitivity and dose rates. This revision, coupled with his publications in the FASEB Journal, has made Liu a leading figure in radiation science. His work in chromosomal aberration analysis and developing noninvasive techniques for early-stage cancer screening underscores his innovative approach to medical research.

IMPACT AND INFLUENCE 🌍

Gang Liu's influence extends beyond national borders. His research on radiological sensitivity and dose rates, especially in the context of cancer screening and radiation therapy, has set new benchmarks in the field. The international recognition of his work, particularly his advancements in biological dose estimation and contributions to global radiation protection protocols, underscores his importance in radiobiology. His work is used by institutions worldwide to improve radiation safety standards and enhance cancer diagnostic techniques.

ACADEMIC CITATIONS 📚

His pioneering research has been published in prestigious journals such as the FASEB Journal, one of the top international platforms for scientific contributions. The citations of his work in radiological sensitivity, chromosomal aberration analysis, and cancer screening techniques reflect his deep impact on the scientific community, with his methods influencing both practical applications in healthcare and further research.

LEGACY AND FUTURE CONTRIBUTIONS 🔬

Gang Liu’s legacy will likely be defined by his leadership in advancing radiation protection technology and cancer screening techniques. As an innovator in radiological health, his influence will continue to grow through future contributions to radiation therapy safety, noninvasive cancer detection, and international health standards. His ongoing work in exploring new methods for biological dose estimation will further establish his standing as a key figure in the evolution of radiation medicine.

NOTABLE PUBLICATIONS 📑

"Study of Low-Dose Radiation Workers Ionizing Radiation Sensitivity Index and Radiation Dose-Effect Relationship" 

  • Authors: Liu, G., Zhang, R., Li, Y., Liu, Y.Y., Zhang, X.
  • Journal: Health Physics
  • Year: 2022

"Revision of cytogenetic dosimetry in the IAEA manual 2011 based on data about radio-sensitivity and dose-rate findings contributing" 

  • Authors:Liu, G.
  • Journal: FASEB Journal
  • Year: 2022

"Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers"

  • Authors: Liu, G., Li, Y., Zhang, H., Niu, L.M., Zhang, R.
  • Journal: Frontiers in Public Health
  • Year: 2022

"Study of Indicators for Early and Rapid Diagnosis of Radiation Injury Is the Most Important in Patients With Cancer During Radiotherapy"

  • Authors: Liu, G., Niu, L.-M., Wang, L.-Q., Liu, Y.-Y., Zhang, R.
  • Journal: Dose-Response
  • Year: 2020

"Chromosomal aberration analysis: Novel noninvasive techniques for early-stage cancer screening"

  • Authors: Liu, G.
  • Journal: Clinica Chimica Acta
  • Year: 2024

Prof Xiuyun Liu | Neuropsychiatric Disorders | Best Researcher Award

Published on by Genetics and Genomics

Prof Xiuyun Liu | Neuropsychiatric Disorders | Best Researcher Award

Pharmaceutical School, Tianjin University | China

Author Profile

Scopus

Orcid Id

Biography of Xiuyun Liu 🎓🧠

EARLY ACADEMIC PURSUITS 📚

Xiuyun Liu's academic journey is marked by a strong foundation in biomedical engineering, which she pursued at Tianjin University, China. She earned both her Bachelor’s and Master’s degrees from the College of Precision Instrument and Opto-electronics Engineering, showcasing her dedication to the intersection of engineering and medical science. Her academic excellence led her to the prestigious University of Cambridge in the UK, where she completed her Ph.D. in Clinical Neurosciences at Newnham College. Supported by the highly competitive Gates Scholarship, her research focused on groundbreaking areas within neurosciences, laying the foundation for her future contributions to medical research.

PROFESSIONAL ENDEAVORS 🏢

Dr. Liu's professional career is as impressive as her academic background. She began as a Postdoctoral Researcher in the Department of Physiological Nursing at the University of California, San Francisco. She then became a Research Fellow in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University. These roles allowed her to deepen her research in critical care medicine and anesthesiology, contributing valuable insights to these fields. Currently, Dr. Liu serves as the Dean of the School of Pharmaceutical and Science Technology at Tianjin University, where she continues to influence the next generation of medical professionals.

CONTRIBUTIONS AND RESEARCH FOCUS ON NEUROPSYCHIATRIC DISORDERS🔬

Dr. Liu has made significant contributions to the field of neurocritical care and biomedical engineering. Her research focuses on the development of innovative technologies and methodologies in critical care and perioperative medicine. As the Executive Director of the National Neurocritical Medicine Innovation Center, she leads research initiatives that aim to revolutionize the management of neurological emergencies. Her work is also closely associated with the development of life support technologies, reflecting her deep commitment to improving patient outcomes in critical care settings.

IMPACT AND INFLUENCE 🌍

Dr. Liu's influence extends beyond her research. She holds key positions in various prestigious organizations, including being a member of the Research Committee of the Society of Critical Care Anesthesiologists (SOCCA) in the USA and the Vice President of the Life Support Technology Branch of the Chinese Medical Rescue Association. Her leadership in these roles underscores her impact on both national and international levels, shaping the future of critical care and anesthesiology.

ACADEMIC CITATIONS AND HONORS 🏆

Dr. Liu’s research has garnered significant attention, leading to numerous citations in academic journals and conferences. Her work has been recognized with multiple awards, including the MIT Innovators 35 Under 35 in 2023, the National Teaching Achievement Award, and the Outstanding Youth of Tianjin University. Additionally, she received the prestigious Bill Gates Scholarship during her time at Cambridge, a testament to her academic prowess and potential for future impact.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

As a leading figure in neurocritical care and biomedical engineering, Dr. Liu's legacy is already being shaped by her contributions to medical research and education. Her future contributions are poised to continue influencing the fields of critical care, life support technology, and medical engineering. With her ongoing leadership roles and innovative research, Dr. Liu is set to leave a lasting impact on the global medical community, inspiring future generations of scientists and medical professionals.

NOTABLE PUBLICATIONS 📑

"Enhancing Motor Sequence Learning via Transcutaneous Auricular Vagus Nerve Stimulation (taVNS): An EEG Study" 

  • Authors: Chen, L., Tang, C., Wang, Z., Liu, X., Ming, D.
  • Journal: IEEE Journal of Biomedical and Health Informatics
  • Year: 2024

"Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms" 

  • Authors: Liu, X.-Y., Song, X., Czosnyka, M., Pang, M.-J., Ming, D.
  • Journal: Military Medical Research
  • Year: 2024

"Photoacoustic imaging in brain disorders: Current progress and clinical applications"

  • Authors: Liu, X., Li, H., Pang, M., Wu, Y., Ming, D.
  • Journal: VIEW
  • Year: 2024

"Heart-brain axis: low blood pressure during off-pump CABG surgery is associated with postoperative heart failure"

  • Authors: Liu, X.-Y., Mu, J.-J., Han, J.-G., Guo, Z.-G., Ming, D.
  • Journal: Military Medical Research
  • Year: 2024

"Molecular understanding of the therapeutic potential of melanin inhibiting natural products"

  • Authors: Pang, M., Xu, R., Xi, R., Liu, X., Ming, D.
  • Journal: RSC Medicinal Chemistry
  • Year: 2024

Havva Ortabozkoyun | Gene Regulation | Best Researcher Award

Published on by Genetics and Genomics

Dr. Havva Ortabozkoyun | Gene Regulation | Best Researcher Award

University of Miami Miller School of Medical / Sylvester Cancer Center | United States

Author Profile

Orcid ID

Google Scholar

🧬 Havva Ortabozkoyun-Kara, PhD: Pioneering Epigenetics and Cancer Biology Researcher

🧑‍🎓 EARLY ACADEMIC PURSUITS

Havva Ortabozkoyun-Kara, PhD, embarked on her academic journey with a Bachelor of Science in Molecular Biology and Genetics from Middle East Technical University (METU) in Ankara, Turkey. Graduating with a stellar GPA of 3.80/4.00 in 2010, she demonstrated early on her dedication to understanding complex biological systems. Her education continued at Utrecht University in the Netherlands, where she pursued a Master of Science in Cancer Genomics and Developmental Biology. With a perfect GPA of 4.00/4.00, she excelled in this program, setting a strong foundation for her future research in cancer biology. Dr. Ortabozkoyun-Kara then achieved her PhD in Stem Cell Biology from New York University (NYU), where she graduated with a GPA of 3.89/4.00. During her doctoral studies, she delved into stem cell and developmental biology, further refining her focus on the mechanisms that drive cellular diversity and disease processes.

🧑‍🔬 PROFESSIONAL ENDEAVORS

Dr. Ortabozkoyun-Kara’s professional journey is marked by her extensive research experience in some of the most prestigious laboratories in the world. She began as a rotation student in the lab of Iannis Aifantis at NYU, where she explored the role of the ubiquitin system in cancer and stem cell function. Her doctoral research, conducted in the lab of Danny Reinberg at NYU School of Medicine, involved pioneering work on the insulation function of CTCF and the characterization of Polycomb Repressive Complex (PRC1) during differentiation. After completing her PhD, she continued her research as a Postdoctoral Fellow in the Reinberg Lab, focusing on gene regulation and the role of MAZ, CTCF, and other factors in disease processes. Currently, she holds a postdoctoral fellowship at the University of Miami Miller School of Medicine, where she is studying novel insulation factors on gene regulation during developmental and disease processes.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATION

Dr. Ortabozkoyun-Kara’s research has significantly advanced our understanding of epigenetics, stem cell biology, and cancer biology. Her work has centered on the intricate mechanisms of gene regulation, particularly the insulation functions that control the expression of Hox genes during development and in disease states. Through innovative CRISPR genetic screens and biochemical assays, she has identified key factors that cooperate with CTCF in these processes. Her research on the differences in Polycomb Repressive Complex composition during cellular differentiation has provided new insights into how these complexes contribute to the regulation of gene expression.

🌍 IMPACT AND INFLUENCE

Dr. Ortabozkoyun-Kara’s contributions to the fields of epigenetics and stem cell biology have had a profound impact on our understanding of how genetic and biochemical mechanisms lead to cellular diversity and disease. Her findings on the role of insulation factors in gene regulation have opened new avenues for research in developmental biology and cancer, influencing the direction of studies in these fields. Her expertise is recognized internationally, and she continues to collaborate with leading scientists to push the boundaries of what we know about gene regulation and its implications for human health.

📚 ACADEMIC CITATIONS

Dr. Ortabozkoyun-Kara’s work has been widely cited in the academic community, reflecting the importance of her contributions to the scientific understanding of gene regulation. Her publications in high-impact journals are frequently referenced by other researchers in the fields of molecular biology, genetics, and biochemistry. These citations underscore the relevance of her work to ongoing research and its potential to inform new therapeutic approaches for diseases linked to epigenetic regulation.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

As Dr. Ortabozkoyun-Kara continues her research at the University of Miami, her legacy is one of innovation and discovery. Her future contributions are expected to further illuminate the complex mechanisms of gene regulation and their role in development and disease. With her deep expertise in epigenetics and stem cell biology, she is poised to make significant advances in the understanding and treatment of diseases driven by genetic and epigenetic alterations. Her work will undoubtedly continue to influence the fields of molecular biology and genetics for years to come, inspiring future generations of scientists.

💡 INNOVATIVE APPROACHES

Dr. Ortabozkoyun-Kara is known for her creative and methodical approaches to scientific research. She has developed novel genetic and biochemical methods that have expanded the toolkit available to researchers studying epigenetic mechanisms. Her work not only provides critical insights but also equips the scientific community with new strategies for investigating and manipulating gene expression in various biological contexts.

📑 NOTABLE PUBLICATIONS

"CRISPR and biochemical screens identify MAZ as a cofactor in CTCF-mediated insulation at Hox clusters" 

  • Authors: Havva Ortabozkoyun, Pin-Yao Huang, Hyunwoo Cho, Varun Narendra, Gary LeRoy, Edgar Gonzalez-Buendia, Jane A Skok, Aristotelis Tsirigos, Esteban O Mazzoni, Danny Reinberg
  • Journal: Nature Genetics
  • Year: 2022

"A CRISPR Screen Identifies Myc-associated Zinc Finger Protein (MAZ) as an Insulator Functioning at CTCF boundaries in Hox Clusters" 

  • Authors: Havva Ortabozkoyun-Kara, Pin-Yao Huang, Hyunwoo Cho, Varun Narendra, Gary Leroy, Jane A. Skok, Aristotelis Tsirigos, Esteban O. Mazzoni, Danny Reinberg
  • Journal: BioRxiv
  • Year: 2020

"Members of an array of zinc finger proteins specify distinct Hox chromatin boundaries"

  • Authors: Havva Ortabozkoyun, Pin-Yao Huang, Edgar Gonzalez-Buendia, Hyein Cho, Sang Kim, Aristotelis Tsirigos, Esteban Mazzoni, Danny Reinberg
  • Journal: bioRxiv
  • Year: 2023

"Members of a Family of Zinc Finger Proteins Demarcate Chromatin Boundaries at Hox Clusters during Development, Ortabozkoyun et. al"

  • Authors: Havva Ortabozkoyun, Pin-Yao Huang, Edgar Gonzalez-Buendia, Hyunwoo Cho, Sang Y Kim, Aristotelis Tsirigos, Esteban O Mazzoni, Danny Reinberg
  • Journal: Mendeley Data
  • Year: 2024

"Novel chromatin insulating activities uncovered upon eliminating known insulators in vivo"

  • Authors: Havva Ortabozkoyun, P. Huang, H. Cho, E. Mazzoni, A. Tsirigos, D. Reinberg
  • Year: 2023

Bruno Fuchs | Sarcoma | Excellence in Innovation

Published on by Genetics and Genomics

Prof Dr. Bruno Fuchs | Sarcoma | Excellence in Innovation 

Swiss Sacroma Network | Switzerland 

Author Profile

Orcid ID

Bruno Fuchs, MD, PhD 🌟

Position: Professor and Chair, Sarcoma Center & Swiss Sarcoma Network

Location: Faculty of Health Science & Medicine, University of Lucerne, and LUKS University Hospital, Luzern, Switzerland

Contact: fuchs@sarcoma.surgery

Educational Background 🎓

  • 2022: Guest-Professor, Medical Faculty, University of Lucerne
  • 2010: Extraordinarius, Medical Faculty, University of Zurich
  • 2005: Associate Professor, Medical Faculty, University of Zurich
  • 2004: PhD in Biomedical Sciences (Tumor Biology), Mayo Graduate School, Mayo College of Medicine, Rochester, MN, USA
  • 1996 - 2004: Training and Fellowship in Orthopedic Surgery and Musculoskeletal Oncology at Mayo Clinic, Rochester, MN, USA, and Swiss institutions
  • 1992: MD, Medical Faculty, University of Zurich, Switzerland

Clinical and Research Expertise 🔬

  • Specializes in the surgical treatment of bone and soft tissue tumors in both pediatric and adult patients
  • Focuses on outcome analysis and quality indicators in sarcoma care
  • Engages in predictive outcome analytics for improving sarcoma treatment

Academic Contributions 📚

  • Authored over 200 publications and book chapters
  • Acquired over 10 million Swiss Francs in research funding
  • Active as a reviewer for prestigious journals and grant committees

Contributions and Research Focus on Sarcoma🏆

Fuchs has made profound contributions to the surgical treatment of bone and soft tissue tumors in both pediatric and adult patients. His research is heavily focused on the outcome analysis of sarcoma patients, defining and assessing quality indicators of sarcoma care, and predictive outcome analytics. His work is vital in improving the standards and methodologies employed in sarcoma care, directly impacting patient outcomes and care quality.

Public and Professional Service 🌐

  • Founder & Chair of the Swiss Sarcoma Network
  • Founder of the Sarcoma Academy
  • Member of multiple medical societies including SwissOrthopaedics, FMH, and CTOS

Dr. Bruno Fuchs is recognized internationally for his extensive contributions to the field of sarcoma research and treatment. His work continues to shape the future of musculoskeletal oncology.

Notable Publications📑

"Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation" 

  • Authors: Philip Heesen, Georg Schelling, Mirko Birbaumer, Ruben Jäger, Beata Bode, Gabriela Studer, Bruno Fuchs
  • Journal: Cancers
  • Year: 2024

"Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome" 

  • Authors: Timothy T. A. F. Obergfell, Kim N. Nydegger, Philip Heesen, Georg Schelling, Beata Bode-Lesniewska, Gabriela Studer, Bruno Fuchs
  • Journal: Cancers
  • Year: 2024

"Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare"

  • Authors: Georg Schelling, Philip Heesen, Boris Malte Tautermann, Markus Wepf, Barbara Di Federico, Annika Frei, Kim van Oudenaarde, Pietro Giovanoli, Beata Bode-Lesniewska, Gabriela Studer et al.
  • Journal: Cancers
  • Year: 2024

"Development and Validation of the Bone Tumor Surgery Complexity Score"

  • Authors: Annika Frei, Georg Schelling, Philip Heesen, Pietro Giovanoli, Bruno Fuchs
  • Journal: Reports
  • Year: 2024

"Exploring Risk Factors for Predicting 30-Day Postoperative Morbidity in Musculoskeletal Tumor Surgery"

  • Authors: Philip Heesen, Maria Elyes, Jan Domanski, Georg Schelling, Sören Könneker, Bruno Fuchs
  • Journal: Journal of Clinical Medicine
  • Year: 2024

Ning Li | Gene Regulations | Best Researcher Award

Published on by Genetics and Genomics

Dr. Ning Li | Gene Regulations | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Li Ning, Ph.D. 🧬

Lecturer, School of Disaster and Emergency Medicine, Faculty of Medicine

Research Areas :🧠

  • Molecular mechanisms of traumatic injury
  • Immunotherapy
  • Mechanobiology

📧 Email: lining620@tju.edu.cn

Brief Introduction:

Dr. Li Ning received her Ph.D. from Nankai University, China, in 2019. Since then, she has been a dedicated lecturer at Tianjin University, where she also supervises master's students. Her research delves into the pathogenic mechanisms of trauma, cell death in trauma-related diseases, immunotherapy, and biomechanics within disaster medicine. Dr. Ning has led numerous national, provincial, and university-level research projects, with her work published in esteemed journals like Nucleic Acids Research, Military Medical Research, Trends in Pharmacological Sciences, Cell Death & Discovery, and Pharmacological Research.

Educational Background 🎓

  • 2008.09 - 2012.07: Bachelor's in Bioscience and Biotechnology, Shenyang Agricultural University
  • 2012.09 - 2015.07: Master's in Medicine, Nankai University
  • 2015.09 - 2018.12: Ph.D. in Pharmacy, Nankai University

Professional Experience 💼

  • 2019.05 - Present: Lecturer, School of Disaster and Emergency Medicine, Faculty of Medicine, Tianjin University

Academic Achievements:

Dr. Li Ning has an impressive list of published research papers, several of which highlight her contributions to the understanding of cell death mechanisms and potential therapeutic targets for trauma management. Additionally, she holds multiple patents, including innovations in nucleic acid detection and crush injury modeling equipment.

Fellowships & Honors 🏆

  • Excellent Master's Thesis, Nankai University (2015)
  • Teaching and Educating Excellence Award, Tianjin University (2022)
  • Scientific Research Rookie Award, Tianjin University (2022)
  • Outstanding Mentor, Tianjin University (2023)
  • Multiple awards for outstanding contributions and excellence in teaching from Tianjin University (2022-2024)

Dr. Ning continues to contribute significantly to the fields of disaster and emergency medicine through her research and teaching.

Journal Publications 📚

  • Nucleic Acids Research
    • Li Ning might have contributed research on the molecular mechanisms of traumatic injury, possibly focusing on DNA damage and repair mechanisms or gene expression changes post-injury.
  • Military Medical Research
    • Research related to trauma, particularly in military settings, could include studies on immunotherapy and the impact of cell death on traumatic injuries, as well as advances in medical biomechanics.
  • Trends in Pharmacological Sciences
    • Likely publications could discuss cutting-edge approaches in immunotherapy or pharmacological interventions targeting trauma-induced pathogenesis.
  • Cell Death & Discovery
    • Studies on the role of cell death in trauma-related diseases, focusing on molecular pathways and therapeutic targets.
  • Pharmacological Research
    • Research papers could include findings on drug interventions for trauma-induced pathologies, including immunotherapeutic strategies and their mechanobiological implications.

Notable Publications 📑

"Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment" 

  • Authors: Qiao, O., Wang, X., Wang, Y., Li, N., Gong, Y.
  • Journal: Journal of Advanced Research
  • Year: 2023

"Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies" 

  • Authors: Li, N., Han, L., Wang, X., Zhang, L., Gong, Y.
  • Journal: Translational Research
  • Year: 2023

"Delayed step-by-step decompression with DSF alleviates skeletal muscle crush injury by inhibiting NLRP3/CASP-1/GSDMD pathway "

  • Authors: Li, N., Wang, X., Wang, Y., Fan, H., Gong, Y.
  • Journal: Cell Death Discovery
  • Year: 2023

"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation"

  • Authors: Yu, J., Du, Y., Liu, C., Wang, Y., Qin, J.
  • Journal: Life Sciences
  • Year: 2024

"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation"

  • Authors: Xie, Y., Shan, M., Yu, J., Lan, L., Wang, Y.
  • Journal: Cancer Science
  • Year: 2024